Study of DSP-1083 for Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests a new treatment called DSP-1083 for people with Parkinson's disease whose symptoms are not well controlled with standard medications. The study will check if it is safe and if it helps improve movement and daily function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 72 years old
- You have had Parkinson's disease for at least 4 years
- Your Parkinson's symptoms are not well controlled with your current medications, including levodopa/carbidopa
- You have both 'on' and 'off' periods where symptoms change
- You have not had deep brain stimulation or similar brain surgery for Parkinson's
- You do not have severe dyskinesia (uncontrolled movements) from your Parkinson's medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special stem cells (made from skin or blood cells) to replace damaged brain cells in people with Parkinson's. The goal is to see if these cells can improve movement and reduce symptoms.
This study tests whether different deep brain stimulation settings can improve symptoms in people with Parkinson’s who already have an implanted DBS system in the subthalamic nucleus (STN). To join, you must already have the specific Medtronic device and show good brain signal and symptom response after surgery.
This study tests an approach to improving Parkinson’s symptoms in people who already have deep brain stimulation (DBS) devices. It focuses on patients who are able to do walking tests safely and confirm they can understand and consent.
This trial tests a new drug, PDR-001, to see if it can safely remove harmful proteins from the brain in people with early Parkinson's disease. It may help slow down the disease.
This trial tests a new treatment called XS411 for people with early-onset Parkinson's disease (age 50 or younger at diagnosis). It is for those whose motor symptoms are not well controlled with standard medications and who may benefit from a neurosurgical procedure.
This study is for people with Parkinson's disease who already have a deep brain stimulator (a device that sends electrical pulses to the brain) and still have motor fluctuations (times when symptoms come and go). The researchers want to see if adapting the device's settings can better control symptoms than the current standard settings.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.